PARI Study Connect vs Trialogics Connect

The PARI Study Connect App is intended for use in clinical trials with an eFlow® Technology nebuliser in conjunction with the eTrack Controller distributed by PARI Pharma GmbH. The app can be used by study participants to document and transfer data on the inhalations performed.

Trialogics Connect provides secure mobile access to clinical trial studies and authorized research systems for enrolled study participants and approved research staff. Participants may use the app to complete electronic questionnaires and diaries, review informed consent materials, and perform study-related activities assigned as part of a clinical trial. Authorized study personnel may securely access study applications and operational tools relevant to their role. Access to Trialogics Connect requires enrollment in a participating clinical study or authorization from a sponsoring organization. The app does not provide medical advice and is not intended to diagnose, treat, or prevent any medical condition. All data is handled in accordance with applicable research and data protection requirements.